|
|
|
 |
Electrochemiluminescence |
|
| |
| Electrochemiluminescence or electrogenerated chemiluminescence (ECL) is a type of luminescence produced during electrochemical reactions in solutions. The ECL platform utilized at Cambridge Biomedical allows the detection of biomarkers in single and multiplex formats in microplate wells.
|
Typical applications of Electrochemiluminescence
|
- Cytokines and chemokines
- Cell signaling Pathways
- Angiogensis and hypoxia markers
- Growth and Vascular Factors
- Metabolic Markers
- Immunogenicity
- Cell-Based Assays
- Immunogenicity
- Vaccine / Bioproduction
|
Advantages of ECL over conventional ELISA
|
- High Sensitivity and Low Background because the stimulation mechanism (electrical) is decoupled from the detection signal (light)
- Emission read at 620 nm, eliminates issues revolving around color quenching
- Improved precision from non-separation-based ("no-wash") immunoassays due to the proximity-based nature of signal generation, where only labels near the surfaces of the electrodes are stimulated
- A large assay dynamic range of five logs
- The carbon electrode plate surface has a 10X greater binding capacity than conventional ELISA microplates
- Multiple analytes can be run in a single well reducing required sample volume
Cambridge Biomedical is CLIA certified, CAP accredited, and provides services that support best laboratory practices and GLP compliance. We help our clients navigate through quality and regulatory requirements from preclinical to IV studies. |
| |
|
|
| |
|
|
 |
CRO SERVICES
"Very good technically. People clearly knew what they were doing - knew how to handle assays, data management."
Pharmaceutical Clinical Trial Manager |
|
|
|
|
|
|
|
|